Cartesian Therapeutics, Inc. Increase (Decrease) in Income Taxes Payable
Cartesian Therapeutics, Inc. (RNAC) reported Increase (Decrease) in Income Taxes Payable of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-07.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable · last filed 2024-03-07
- Cartesian Therapeutics, Inc. increase (decrease) in income taxes payable for the quarter ending 2023-12-31 was $0.00.
- Cartesian Therapeutics, Inc. increase (decrease) in income taxes payable for the quarter ending 2023-09-30 was $0.00.
- Cartesian Therapeutics, Inc. increase (decrease) in income taxes payable for the quarter ending 2023-06-30 was $0.00, a 100.00% decline year-over-year.
- Cartesian Therapeutics, Inc. increase (decrease) in income taxes payable for the quarter ending 2023-03-31 was $0.00.
- Cartesian Therapeutics, Inc. increase (decrease) in income taxes payable for fiscal 2023 was $0.00.
- Cartesian Therapeutics, Inc. increase (decrease) in income taxes payable for fiscal 2022 was -$601.00K, a 200.00% decline from fiscal 2021.
- Cartesian Therapeutics, Inc. increase (decrease) in income taxes payable for fiscal 2021 was $601.00K.
- Cartesian Therapeutics, Inc. increase (decrease) in income taxes payable for fiscal 2020 was $0.00.
| Period end | Increase (Decrease) in Income Taxes Payable 3 month | Increase (Decrease) in Income Taxes Payable 6 month | Increase (Decrease) in Income Taxes Payable 9 month | Increase (Decrease) in Income Taxes Payable 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $0.00 derived: sum of 2 quarters · filed 2024-03-07 | $0.00 derived: sum of 3 quarters · filed 2024-03-07 | $0.00 10-K · filed 2024-03-07 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $0.00 derived: sum of 2 quarters · filed 2023-11-13 | $0.00 10-Q · filed 2023-11-13 | $0.00 derived: sum of 4 quarters · filed 2024-03-07 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-17 | $0.00 10-Q · filed 2023-08-17 | $0.00 derived: sum of 3 quarters · filed 2024-03-07 | -$321.00K derived: sum of 4 quarters · filed 2024-03-07 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-04 | $0.00 derived: sum of 2 quarters · filed 2024-03-07 | -$321.00K derived: sum of 3 quarters · filed 2024-03-07 | -$320.00K derived: sum of 4 quarters · filed 2024-03-07 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | -$321.00K derived: sum of 2 quarters · filed 2024-03-07 | -$320.00K derived: sum of 3 quarters · filed 2024-03-07 | -$601.00K 10-K · filed 2024-03-07 |
| 2022-09-30 | -$321.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$320.00K derived: sum of 2 quarters · filed 2023-11-13 | -$601.00K 10-Q · filed 2023-11-13 | -$15.83M derived: sum of 4 quarters · filed 2024-03-07 |
| 2022-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-17 | -$280.00K 10-Q · filed 2023-08-17 | -$15.51M derived: sum of 3 quarters · filed 2024-03-07 | $321.00K derived: sum of 4 quarters · filed 2024-03-07 |
| 2022-03-31 | -$281.00K 10-Q · filed 2023-05-04 | -$15.51M derived: sum of 2 quarters · filed 2024-03-07 | $320.00K derived: sum of 3 quarters · filed 2024-03-07 | $320.00K derived: sum of 4 quarters · filed 2024-03-07 |
| 2021-12-31 | -$15.23M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $601.00K derived: sum of 2 quarters · filed 2024-03-07 | $601.00K derived: sum of 3 quarters · filed 2024-03-07 | $601.00K 10-K · filed 2024-03-07 |
| 2021-09-30 | $15.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $15.83M derived: sum of 2 quarters · filed 2022-11-03 | $15.83M 10-Q · filed 2022-11-03 | $15.83M derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $0.00 10-Q · filed 2022-08-08 | $0.00 derived: sum of 3 quarters · filed 2023-03-02 | |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-05 | $0.00 derived: sum of 2 quarters · filed 2023-03-02 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $0.00 10-K · filed 2023-03-02 | ||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-09 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |